Sarepta Therapeutics
SRPT
#1513
Rank
NZ$20.09 B
Marketcap
$210.36
Share price
-0.42%
Change (1 day)
45.91%
Change (1 year)
Sarepta Therapeutics is an American medical research company dedicated to the discovery and development of precisely effective gene therapeutics for the treatment of rare neuromuscular diseases.

Sarepta Therapeutics (SRPT) - Total debt

Total debt on the balance sheet as of September 2024 : NZ$2.47 Billion

According to Sarepta Therapeutics 's latest financial reports the company's total debt is NZ$2.47 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Sarepta Therapeutics - Total debt on balance sheet (from 2007 to 2024)

Total debt by year

Year Total debt Change
2023-12-31NZ$2.20 B-13.3%
2022-12-31NZ$2.54 B50.85%
2021-12-31NZ$1.68 B13.57%
2020-12-31NZ$1.48 B37.25%
2019-12-31NZ$1.08 B72.79%
2018-12-31NZ$0.62 B3.3%
2017-12-31NZ$0.60 B2503.23%
2016-12-31NZ$23.31 M-31.8%
2015-12-31NZ$34.18 M323.29%
2014-12-31NZ$8.07 M297.89%
2013-12-31NZ$2.02 M-4.96%
2012-12-31NZ$2.13 M-9.51%
2011-12-31NZ$2.36 M-5.31%
2010-12-31NZ$2.49 M-9.52%
2009-12-31NZ$2.75 M-38.27%
2008-12-31NZ$4.46 M59.62%
2007-12-31NZ$2.79 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
NZ$41.10 B 1,563.53%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$0.41 B-83.31%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$13.44 M-99.46%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$1.43 B-42.10%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$2.30 B-6.85%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$0.70 B-71.36%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$1.76 B-28.46%๐Ÿ‡บ๐Ÿ‡ธ USA